Search Results - "Andric, Nada"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study

    Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study by Fathima, Parveen, Jones, Mark, D'Souza, Reena, Totterdell, James, Andric, Nada, Abbott, Penelope, Norman, Richard, Howard, Kirsten, Cheng, Wendy, Pedrana, Alisa, Doyle, Joseph S, Davies, Jane, Snelling, Thomas

    “…Untreated hepatitis C virus (HCV) infection can result in cirrhosis and hepatocellular cancer. Direct-acting antiviral (DAA) therapies are highly effective and…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C

    A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C by Ramsay, Jessica, Marsh, Julie, Pedrana, Alisa, Andric, Nada, Norman, Richard, Cheng, Wendy, Webb, Steve, Zeps, Nikolajs, Bellgard, Matthew, Graves, Todd, Hellard, Margaret, Snelling, Tom

    Published in BMC infectious diseases (29-10-2020)
    “…Abstract Background Safe, highly curative, short course, direct acting antiviral (DAA) therapies are now available to treat chronic hepatitis C. DAA therapy is…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol

    Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol by Doyle, Joseph S, Heath, Katherine, Elsum, Imogen, Douglass, Caitlin, Wade, Amanda, Kasza, Jessica, Allardice, Kate, Von Bibra, Sally, Chan, Kico, Camesella, Beatriz, Guzman, Rodney, Bryant, Mellissa, Thompson, Alexander J, Stoové, Mark A, Snelling, Thomas L, Scott, Nick, Spelman, Timothy, Anderson, David, Richmond, Jacqui, Howell, Jessica, Andric, Nada, Dietze, Paul M, Higgs, Peter, Sacks‐Davis, Rachel, Forbes, Andrew B, Hellard, Margaret E, Pedrana, Alisa E

    Published in BMJ open (02-07-2024)
    “…IntroductionDespite universal access to government-funded direct-acting antivirals (DAAs) in 2016, the rate of hepatitis C treatment uptake in Australia has…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: